1'752 companies found
Galapagos GmbH
Basel · Since 2017
Galapagos is a biotechnology company whose core activity lies in the development and manufacture of innovative medicines, particularly in the fields of oncology and immunology. The company's activities include the development of cell therapies and small molecules, as well as the production of CAR-T cells and biologics. The company has a decentralized cell therapy production platform and a comprehensive pipeline of medicines in various stages of development.
Galvita AG
Basel · Since 2020
Galvita's core activity is the development and manufacture of galenics, i.e. pharmaceutical formulations and active ingredients for the pharmaceutical industry.
GBT Pharma GmbH
Fribourg · Since 2010
The core activity of GBT Pharma is the development of international markets for consumer healthcare products, particularly in the over-the-counter (OTC) segment. The company supports its customers in international market entry and development, including product development and marketing.
GE Healthcare AG
Glattbrugg · Since 2000
GE Healthcare AG is a medical technology company that provides imaging systems and modalities including ultrasound, CT, MRI, mammography and molecular imaging. It also supplies contrast media and nuclear imaging agents, patient monitoring and perioperative solutions, healthcare IT and digital services, alongside lifecycle services such as maintenance, predictive services, cybersecurity and financing.
Genpax SA
Gsteig B. Gstaad · Since 2020
Genpax SA provides an automated whole genome sequencing (WGS) analysis platform to identify bacterial pathogens and antimicrobial resistance and to generate comparable data across sites. The IDEM platform supports use in healthcare, public health, One Health and research settings.
Gigabases Switzerland AG
Reinach Bl · Since 2018
Gigabases Switzerland AG operates a web-based platform for 3D protein design and ordering sequence-verified expression plasmids. The platform provides a database of over 214 million protein 3D structures, tools to modify proteins at the amino-acid level, and algorithms that translate designs into ready-to-order plasmids for mammalian, viral, or bacterial expression.
Gilead Sciences Switzerland Sàrl
Zug · Since 2006
The core activity of Gilead is the development and manufacture of pharmaceuticals, particularly for the treatment of severe and life-threatening diseases such as HIV, liver diseases and cancer.
Gimmune GmbH
Zug · Since 2008
The core activity of Gimmune GmbH is the development and production of innovative medical products, particularly: Anti-cancer and anti-viral compounds, Anti-glycan antibodies, Nano-devices for single-cell analysis, Monoclonal antibodies, especially Anti-glyconectin antibodies. The company focuses on research and development (R&D) in the fields of oncology and virology and offers products and services in these areas.
GlaxoSmithKline AG Zweigniederlassung Baar/Zug
Baar · Since 2019
GlaxoSmithKline AG Zweigniederlassung Baar/Zug is a branch of the biopharmaceutical company GSK, engaged in research, development and commercialization of medicines, vaccines and healthcare products, with R&D focused on respiratory, immunology and inflammation, oncology, HIV and infectious diseases.
Gliapharm SA
Geneva · Since 2017
Gliapharm SA develops medicines that target glial cells to enhance brain energy metabolism and support neuronal function. The company uses its GliaX™ discovery platform to identify molecular targets and small‑molecule candidates and advances preclinical translational models and biomarkers.
Global Pharmacare AG
Basel · Since 2006
Global Pharmacare AG provides services for the pharmaceutical sector, including sourcing new molecules, technology transfer for formulation technologies, and development of custom pellet-based delivery systems. Its services also include preparing registration documentation, supporting regulatory submissions, providing financial support, arranging factory audits, and handling distribution and logistics for diagnostic and pharmaceutical products.
GlycoEra AG
Wädenswil · Since 2020
The core activity of GlycoEra is the development of innovative biologics based on a glycoengineering platform, particularly for the treatment of autoimmune diseases and neurological disorders through protein degradation.
Gonadosan GmbH
St. Gallen · Since 2009
Gonadosan GmbH markets the Fertilovit brand of dietary supplements that support fertility, pregnancy and breastfeeding. The product range includes targeted formulations for women and men, including preparations for PCOS, Hashimoto, endometriosis and limited semen quality.
Granite Bio AG
Basel · Since 2021
Granite Bio AG is a biotechnology company developing first-in-class therapeutic antibodies for inflammatory, autoimmune and fibrotic diseases. Its pipeline includes GRT-001, an antibody that depletes pro-inflammatory monocytes and is in Phase 1b for inflammatory bowel disease, and GRT-002, an interleukin-3–blocking antibody in preclinical development expected to enter clinical trials in 2026.
Green Gold Health SA
Puidoux · Since 2019
The company's core activity encompasses the production and distribution of: 1. Pharmaceutical products, including accessible and affordable medications, anesthetics (e.g. Propofol) and medicines for the treatment of Covid-19. 2. CBD cosmetics and supplements, including creams, oils and water-soluble CBD products designed for skin health and overall well-being. 3. Innovative supplements, such as sports nutrition supplements, anti-hangover pills and supplements for the prevention of Covid-19. 4. In-vitro diagnostics, including PCR tests, antigen tests and devices for the diagnosis of Covid-19 infections. The company operates globally and has subsidiaries in Switzerland, Spain, Hong Kong and China.
GRG Gene Technology SA
Contone · Since 2014
The core activity of GRG Gene Technology is the development of innovative therapeutic strategies for cardiovascular diseases through the application of plant biotechnology to human health. In particular, the company focuses on the development of anti-atherogenic APOA-1 mutants that can be administered in a safe and cost-effective manner to deliver optimal doses of the active ingredient.
Grow Motion AG
Zuchwil · Since 2020
Grow Motion AG cultivates and supplies medical cannabis and CBD products. The company operates an indoor production facility following a 'seed to sell' approach with controlled cultivation, drying and quality-control processes. Offerings include CBD oils and CBD flower, sold via its online shop and to wholesale customers.
Grünenthal Pharma AG
Mitlödi · Since 1993
Grünenthal Pharma AG is a pharmaceutical company focused on research and the marketing of prescription medicines for pain and inflammatory conditions. The Swiss subsidiary manages commercialization of products from group R&D and from licensing partnerships; the group in Switzerland also includes production and trading entities such as Proto Chemicals AG (active substance manufacturing) and Protopharm AG (pharmaceutical trading).
GT Gain Therapeutics SA
Lugano · Since 2024
The company is active in the field of biopharmaceuticals (bio-pharma).
Guerbet Imaging Switzerland AG
Zug · Since 2013
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register